FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016357461> ?p ?o ?g. }

• W2016357461 endingPage "175" @default.
• W2016357461 startingPage "169" @default.
• W2016357461 abstract "This study explored the efficacy and toxicity of the combinatino of pentostatin and rituximab, effective single agents in low-grade non- Hodgkin's lymphoma (NHL). Sixty patients with previously treated low-grade NHL were enrolled. Except for day 1, both drugs were administered weekly for 4 weeks, with week 5 off. During week 1 (day 1) only rituximab was given; subsequent weekly treatments included both drugs. Patients received a minimum of 2 five-week cycles in order to be evaluable for efficacy. Responses were evaluated on week 5 of cycle 2. If partial response (PR) or stable disease (SD) responses were noted, 2 additional cycles were administered. Final evaluations were done on week 5 of cycle 4. Of 60 patients, 58.3% had an Eastern Cooperative Oncology Group performance status (PS) of 0, and 41.7% had PS of 1; 31.7% and 51.7% had stage III or stage IV disease, respectively. Histology included follicular center, follicular, grade I (45%), II (21.7%), III (1.7%), and small lymphocytic (31.7%). Seventeen patients had prior chemotherapy, but no patients had received prior pentostatin or rituximab. Median age was 60.3 years (range, 32.5-84.7 years). Among 57 evaluable patients, 77% responded (22.3% complete response [CR], 3.5% unconfirmed CR, 35.1% PR, and 10.5% unconfirmed PR); 19.3% had SD, and 8.8% progressive disease (PD). Response rate among previously untreated patients was 83% versus 63% in previously treated patients. Median duration of response was 11 months (range, 2.3-22.2 months); median time to progression was 15 months (range,< 1-25 months). Neutropenia was the only adverse event experienced by ≥ 10% of patients. Six deaths were causedy by PD, and one death each was caused by acute respiratory distress, possibly related respiratory failure, and cardiac toxicity. These results suggest the combination of pentostatin/rituximab is well tolerated and active in low-grade lymphoma." @default.
• W2016357461 created "2016-06-24" @default.
• W2016357461 creator A5000091883 @default.
• W2016357461 creator A5025151273 @default.
• W2016357461 creator A5028916394 @default.
• W2016357461 creator A5030718981 @default.
• W2016357461 creator A5035967034 @default.
• W2016357461 creator A5047894550 @default.
• W2016357461 creator A5062382526 @default.
• W2016357461 creator A5078514750 @default.
• W2016357461 creator A5090293930 @default.
• W2016357461 date "2003-12-01" @default.
• W2016357461 modified "2023-09-27" @default.
• W2016357461 title "Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen" @default.
• W2016357461 cites W1912693401 @default.
• W2016357461 cites W1915689252 @default.
• W2016357461 cites W1970346572 @default.
• W2016357461 cites W1985901313 @default.
• W2016357461 cites W1997816635 @default.
• W2016357461 cites W1997879818 @default.
• W2016357461 cites W1998483083 @default.
• W2016357461 cites W2002359348 @default.
• W2016357461 cites W2016837049 @default.
• W2016357461 cites W2025697028 @default.
• W2016357461 cites W2069617608 @default.
• W2016357461 cites W2084899812 @default.
• W2016357461 cites W2085259518 @default.
• W2016357461 cites W2098731861 @default.
• W2016357461 cites W2104334201 @default.
• W2016357461 cites W2123602110 @default.
• W2016357461 cites W2129041705 @default.
• W2016357461 cites W2149103702 @default.
• W2016357461 cites W2154495833 @default.
• W2016357461 cites W2167635913 @default.
• W2016357461 cites W2264636885 @default.
• W2016357461 cites W2267793562 @default.
• W2016357461 cites W278980342 @default.
• W2016357461 cites W4230324843 @default.
• W2016357461 doi "https://doi.org/10.3816/clm.2003.n.026" @default.
• W2016357461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14715099" @default.
• W2016357461 hasPublicationYear "2003" @default.
• W2016357461 type Work @default.
• W2016357461 sameAs 2016357461 @default.
• W2016357461 citedByCount "19" @default.
• W2016357461 countsByYear W20163574612014 @default.
• W2016357461 countsByYear W20163574612016 @default.
• W2016357461 countsByYear W20163574612017 @default.
• W2016357461 countsByYear W20163574612020 @default.
• W2016357461 crossrefType "journal-article" @default.
• W2016357461 hasAuthorship W2016357461A5000091883 @default.
• W2016357461 hasAuthorship W2016357461A5025151273 @default.
• W2016357461 hasAuthorship W2016357461A5028916394 @default.
• W2016357461 hasAuthorship W2016357461A5030718981 @default.
• W2016357461 hasAuthorship W2016357461A5035967034 @default.
• W2016357461 hasAuthorship W2016357461A5047894550 @default.
• W2016357461 hasAuthorship W2016357461A5062382526 @default.
• W2016357461 hasAuthorship W2016357461A5078514750 @default.
• W2016357461 hasAuthorship W2016357461A5090293930 @default.
• W2016357461 hasConcept C126322002 @default.
• W2016357461 hasConcept C141071460 @default.
• W2016357461 hasConcept C2775952470 @default.
• W2016357461 hasConcept C2776694085 @default.
• W2016357461 hasConcept C2777058707 @default.
• W2016357461 hasConcept C2777063308 @default.
• W2016357461 hasConcept C2778476748 @default.
• W2016357461 hasConcept C2778822529 @default.
• W2016357461 hasConcept C2779338263 @default.
• W2016357461 hasConcept C2780653079 @default.
• W2016357461 hasConcept C2781413609 @default.
• W2016357461 hasConcept C71924100 @default.
• W2016357461 hasConcept C90924648 @default.
• W2016357461 hasConceptScore W2016357461C126322002 @default.
• W2016357461 hasConceptScore W2016357461C141071460 @default.
• W2016357461 hasConceptScore W2016357461C2775952470 @default.
• W2016357461 hasConceptScore W2016357461C2776694085 @default.
• W2016357461 hasConceptScore W2016357461C2777058707 @default.
• W2016357461 hasConceptScore W2016357461C2777063308 @default.
• W2016357461 hasConceptScore W2016357461C2778476748 @default.
• W2016357461 hasConceptScore W2016357461C2778822529 @default.
• W2016357461 hasConceptScore W2016357461C2779338263 @default.
• W2016357461 hasConceptScore W2016357461C2780653079 @default.
• W2016357461 hasConceptScore W2016357461C2781413609 @default.
• W2016357461 hasConceptScore W2016357461C71924100 @default.
• W2016357461 hasConceptScore W2016357461C90924648 @default.
• W2016357461 hasIssue "3" @default.
• W2016357461 hasLocation W20163574611 @default.
• W2016357461 hasLocation W20163574612 @default.
• W2016357461 hasOpenAccess W2016357461 @default.
• W2016357461 hasPrimaryLocation W20163574611 @default.
• W2016357461 hasRelatedWork W1970884884 @default.
• W2016357461 hasRelatedWork W1997629499 @default.
• W2016357461 hasRelatedWork W2005708883 @default.
• W2016357461 hasRelatedWork W2073341443 @default.
• W2016357461 hasRelatedWork W2081460859 @default.
• W2016357461 hasRelatedWork W2112679438 @default.
• W2016357461 hasRelatedWork W2374533761 @default.
• W2016357461 hasRelatedWork W2408094891 @default.
• W2016357461 hasRelatedWork W2412172283 @default.

• next